1, Hong Sheng Science and Technology 300476: The total revenue in 2020 is 5.6 billion, up 44.15% year-on-year; The net profit was 5,654.38+0.9 million, a year-on-year increase of 65,438+0.2.13%; The gross profit margin of sales is 23.66%.

2. The annual report of Gloria Ying 00282 1: 2020 shows that Gloria Ying achieved revenue of 310.50 billion, up by 28.04% year-on-year; The net profit was 722 million, a year-on-year increase of 30.37%; The gross profit margin is 46.55%.

3. The annual report of Tiger Medicine 300347: 2020 shows that Tiger Medicine achieved revenue of 365,438+92 million, a year-on-year increase of13.88%; The net profit is 65.438+0.75 billion. In addition to financial returns, the company believes that with the growth and success of these start-ups, these equity investments will help the company to get in touch with emerging technologies, gain potential customers and seize more business opportunities.

4. OPUS 300595: The total revenue in 2020 is 8,765,438+billion, up 34.59% year-on-year; The net profit was 433 million. As of March 3, 2065438, Fidelity Fund (HK) Co., Ltd.-client funds held 0.9598%, China Construction Bank Co., Ltd.-China Europe New Blue Chip Flexible Configuration Hybrid Securities Investment Fund held 0.8367%, and China Construction Bank Co., Ltd.-Nord Value Advantage Hybrid Securities Investment Fund held 0.8062%.

5. Changchun High-tech 000661:The total revenue in 2020 was 8.577 billion, up16.35438+0% year-on-year; The net profit was 3.047 billion, a year-on-year increase of 765,438+0.64%; The gross profit margin of sales is 86.69%.

6. Fan Jian Bio 300529: In 2020, the company realized operating income of 195 1 billion yuan, up by 36.24% year-on-year; The net profit was 875 million yuan, a year-on-year increase of 53.33%; The gross profit margin is 85.24%. In the process of competition with international enterprises, China's high-quality medical device enterprises have grown rapidly, and gradually have the comprehensive strength and technical level to participate in international competition.

The so-called growth stocks refer to the stocks with small scale, thriving business, good management, rich profits and strong competitiveness in the market when listed companies issue them. Excellent growth enterprises generally have the following characteristics: the profits of growth stock companies will reach a new peak in every economic cycle, and will be higher every time; Strong product development and market development ability; Always in the leading position in the industry, with strong comprehensive and core competitiveness; Have an excellent management team. The funds of growth companies are mostly used to build factories, purchase equipment, increase employees, strengthen scientific research, and invest operating profits in the future development of the company, but dividends are often rare. Investors of growth stocks should take a long-term view and hold them for as long as possible in order to get rich profits from the rise of stock prices.